Undervalued over 20% based on DCF

Results

5091

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

5091 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
GOOGL
US$333.664.4%76.4%US$4.1tUS$426.9516.7-0.8%0.3%Media
MSFT
US$451.1018.2%-15.4%US$2.9tUS$561.5825.014.0%0.8%Software
META
US$539.03-9.4%-28.1%US$1.4tUS$775.7920.114.4%0.4%Media
BRK.A
US$764,990.013.8%6.3%US$1.1tUS$764,712.0015.2-2.4%n/aDiversified Financials
LLY
US$1,154.97-2.6%56.1%US$1.1tUS$1,276.9640.716.6%0.6%Pharmaceuticals & Biotech
JPM
US$350.850.3%18.4%US$916.3bUS$371.852.61.4%1.7%Banks
XOM
US$156.970.05%40.6%US$649.6bUS$167.2325.79.6%2.6%Energy
JNJ
US$255.82-1.3%55.3%US$639.9bUS$270.5929.39.8%2.1%Pharmaceuticals & Biotech
688825
CN¥53.97n/an/aCN¥3.5tCN¥61.70128.027.7%n/aSemiconductors
ABBV
US$257.410.2%36.2%US$465.2bUS$268.68126.526.5%2.7%Pharmaceuticals & Biotech
CVX
US$192.31-1.1%26.8%US$379.4bUS$215.0034.511.1%3.7%Energy
HSBA
UK£15.873.9%72.0%UK£272.1bUK£14.661.911.3%3.5%Banks
PG
US$143.96-2.0%-4.3%US$340.2bUS$161.0020.93.5%3.0%Household
MRK
US$129.79-0.5%66.1%US$322.0bUS$135.1935.921.2%2.6%Pharmaceuticals & Biotech
NFLX
US$73.174.4%-36.8%US$304.5bUS$94.3322.311.4%n/aMedia
PLTR
US$122.26-0.5%-20.7%US$293.1bUS$182.20128.531.9%n/aSoftware
AZN
UK£127.200.3%12.3%UK£197.3bUK£159.1125.413.8%1.9%Pharmaceuticals & Biotech
NESN
CHF 82.383.9%15.9%CHF 211.9bCHF 88.8728.512.7%3.8%Food, Beverage & Tobacco
BABA
US$116.322.0%-3.6%US$262.4bUS$189.3716.915.5%0.9%Retail
WFC
US$85.43-0.9%6.0%US$253.6bUS$100.021.63.3%2.3%Banks
SIE
€281.104.8%25.0%€215.7b€295.1528.312.5%1.9%Capital Goods
8306
JP¥3,571.00-4.9%67.9%JP¥39.7tJP¥3,596.362.112.2%2.7%Banks
DELL
US$404.81-7.9%205.1%US$238.8bUS$502.7831.116.8%0.6%Tech
AXP
US$337.52-1.0%12.8%US$223.9bUS$374.5420.29.3%1.1%Diversified Financials
Page 1 of 142
Undervalued over 20% based on DCF - Investing Ideas - Simply Wall St